J. B. Cannata-andia, P. Roman-garcia, and K. Hruska, The connections between vascular calcification and bone health, Nephrology Dialysis Transplantation, vol.26, issue.11, pp.3429-3436, 2011.
DOI : 10.1093/ndt/gfr591
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176055

M. Laroche, V. Pecourneau, H. Blain, V. Breuil, R. Chapurlat et al., Osteoporosis and ischemic cardiovascular disease, Joint Bone Spine, vol.84, issue.4, 2016.
DOI : 10.1016/j.jbspin.2016.09.022

L. C. Hofbauer, C. C. Brueck, C. M. Shanahan, M. Schoppet, and H. Dobnig, Vascular calcification and osteoporosis?from clinical observation towards molecular understanding, Osteoporosis International, vol.16, issue.3, pp.251-259, 2007.
DOI : 10.1172/JCI17202

N. Bucay, I. Sarosi, C. R. Dunstan, S. Morony, J. Tarpley et al., osteoprotegerin-deficient mice develop early onset osteoporosis and arterial?calcification, Genes & Development, vol.12, issue.9, pp.1260-1268, 1998.
DOI : 10.1101/gad.12.9.1260
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC316769/pdf

M. Kuro-o, Y. Matsumura, H. Aizawa, H. Kawaguchi, T. Suga et al., Mutation of the mouse klotho gene leads to a syndrome resembling ageing, Nature, vol.390, issue.6655, pp.45-51, 1997.
DOI : 10.1038/36285

J. Marulanda, C. Gao, H. Roman, J. E. Henderson, and M. Murshed, Prevention of arterial calcification corrects the low bone mass phenotype in MGP-deficient mice, Bone, vol.57, issue.2, pp.499-508, 2013.
DOI : 10.1016/j.bone.2013.08.021

Q. Li, Q. Jiang, E. Pfendner, A. Varadi, and J. Uitto, Pseudoxanthoma elasticum: clinical phenotypes, molecular genetics and putative pathomechanisms, Experimental Dermatology, vol.131, issue.1, pp.1-11, 2009.
DOI : 10.1016/S0002-9394(14)71398-4
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349969

O. , L. Saux, Z. Urban, C. Tschuch, K. Csiszar et al., Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum, Nature Genetics, vol.25, issue.2, pp.223-227, 2000.
DOI : 10.1038/76102

R. S. Jansen, S. Duijst, S. Mahakena, D. Sommer, F. Szeri et al., ABCC6-Mediated ATP Secretion by the Liver Is the Main Source of the Mineralization Inhibitor Inorganic Pyrophosphate in the Systemic Circulation--Brief Report, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.34, issue.9, pp.1985-1989, 2014.
DOI : 10.1161/ATVBAHA.114.304017

R. S. Jansen, A. Kucukosmanoglu, M. De-haas, S. Sapthu, J. A. Otero et al., ABCC6 prevents ectopic mineralization seen in pseudoxanthoma elasticum by inducing cellular nucleotide release, Proceedings of the National Academy of Sciences, vol.72, issue.2, pp.110-20206, 2013.
DOI : 10.1124/mol.107.035592
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864344

N. Chassaing, L. Martin, J. Mazereeuw, L. Barrie, S. Nizard et al., Novel ABCC6 Mutations in Pseudoxanthoma Elasticum, Journal of Investigative Dermatology, vol.122, issue.3, pp.608-613, 2004.
DOI : 10.1111/j.0022-202X.2004.22312.x
URL : http://doi.org/10.1111/j.0022-202x.2004.22312.x

R. Zarbock, D. Hendig, C. Szliska, K. Kleesiek, and C. Gotting, Analysis of MMP2 promoter polymorphisms in patients with pseudoxanthoma elasticum, Clinica Chimica Acta, vol.411, issue.19-20, pp.19-20, 2010.
DOI : 10.1016/j.cca.2010.06.006

G. M. London, Bone-vascular cross-talk, Journal of Nephrology, vol.25, issue.5, pp.619-625, 2012.
DOI : 10.5301/jn.5000187

M. Lebwohl, K. Neldner, F. M. Pope, A. De-paepe, A. M. Christiano et al., Classification of pseudoxanthoma elasticum: Report of a consensus conference, Journal of the American Academy of Dermatology, vol.30, issue.1, pp.103-107, 1994.
DOI : 10.1016/S0190-9622(08)81894-4

D. Laurier, P. C. Nguyen, B. Cazelles, and P. Segond, Estimation of CHD risk in a French working population using a modified Framingham model. The PCV-METRA Group, J. Clin. Epidemiol, vol.47, pp.12-1353, 1994.

A. S. Agatston, W. R. Janowitz, F. J. Hildner, N. R. Zusmer, M. Viamonte-jr et al., Quantification of coronary artery calcium using ultrafast computed tomography, Journal of the American College of Cardiology, vol.15, issue.4, pp.827-832, 1990.
DOI : 10.1016/0735-1097(90)90282-T
URL : http://doi.org/10.1016/0735-1097(90)90282-t

G. Leftheriotis, G. Kauffenstein, J. F. Hamel, P. Abraham, O. L. Saux et al., The Contribution of Arterial Calcification to Peripheral Arterial Disease in Pseudoxanthoma Elasticum, PLoS ONE, vol.48, issue.5, p.96003, 2014.
DOI : 10.1371/journal.pone.0096003.t003

H. K. Genant, C. Y. Wu, C. Van-kuijk, and M. C. Nevitt, Vertebral fracture assessment using a semiquantitative technique, Journal of Bone and Mineral Research, vol.13, issue.S1, pp.1137-1148, 1993.
DOI : 10.1148/radiology.160.2.3726129

N. A. Rashdan, F. Rutsch, H. Kempf, A. Varadi, G. Leftheriotis et al., New perspectives on rare connective tissue calcifying diseases, Current Opinion in Pharmacology, vol.28, pp.28-42, 2016.
DOI : 10.1016/j.coph.2016.02.002
URL : https://hal.archives-ouvertes.fr/hal-01474535

P. Sambrook, C. Cooper, and O. , Osteoporosis, The Lancet, vol.367, issue.9527, pp.2010-2018, 2006.
DOI : 10.1016/S0140-6736(06)68891-0

N. F. Ray, J. K. Chan, M. Thamer, and L. J. Melton-3rd, Medical Expenditures for the Treatment of Osteoporotic Fractures in the United States in 1995: Report from the National Osteoporosis Foundation, Journal of Bone and Mineral Research, vol.10, issue.4, pp.24-35, 1997.
DOI : 10.1111/j.1532-5415.1995.tb05557.x

L. T. Ho-pham, U. D. Nguyen, and T. V. Nguyen, Association Between Lean Mass, Fat Mass, and Bone Mineral Density: A Meta-analysis, The Journal of Clinical Endocrinology & Metabolism, vol.99, issue.1, pp.30-38, 2014.
DOI : 10.1210/jc.2013-3190

Q. Jiang, Q. Li, and J. Uitto, Aberrant Mineralization of Connective Tissues in a Mouse Model of Pseudoxanthoma Elasticum: Systemic and Local Regulatory Factors, Journal of Investigative Dermatology, vol.127, issue.6, pp.1392-1402, 2007.
DOI : 10.1038/sj.jid.5700729

J. T. Chow, S. Khosla, L. J. Melton-3rd, E. J. Atkinson, J. J. Camp et al., Abdominal Aortic Calcification, BMD, and Bone Microstructure: A Population-Based Study, Journal of Bone and Mineral Research, vol.19, issue.Suppl, pp.1601-1612, 2008.
DOI : 10.1161/01.ATV.19.9.2189
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605688

B. N. Andersen, P. B. Johansen, and B. Abrahamsen, Proton pump inhibitors and osteoporosis, Current Opinion in Rheumatology, vol.28, issue.4, pp.420-425, 2016.
DOI : 10.1097/BOR.0000000000000291

M. Fusaro, M. Noale, G. Tripepi, S. Giannini, A. D. Angelo et al., Long-Term Proton Pump Inhibitor Use is Associated with Vascular Calcification in Chronic Kidney Disease: A Cross-Sectional Study Using Propensity Score Analysis, Drug Safety, vol.21, issue.2, pp.36-635, 2013.
DOI : 10.1097/MEG.0b013e3283200047

Q. Li, J. P. Sundberg, M. A. Levine, S. F. Terry, and J. Uitto, The effects of bisphosphonates on ectopic soft tissue mineralization caused by mutations in the ABCC6 gene, Cell Cycle, p.0, 2015.

K. A. Ramjan, T. Roscioli, F. Rutsch, D. Sillence, and C. F. Munns, Generalized arterial calcification of infancy: treatment with bisphosphonates, Nature Clinical Practice Endocrinology & Metabolism, vol.41, issue.3, pp.167-172, 2009.
DOI : 10.1002/ajmg.a.30800

E. G. Neven, M. E. De-broe, and P. C. , Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge?, Kidney International, vol.75, issue.6, pp.580-582, 2009.
DOI : 10.1038/ki.2008.663

M. C. Yadav, A. M. Simao, S. Narisawa, C. Huesa, M. D. Mckee et al., Loss of skeletal mineralization by the simultaneous ablation of PHOSPHO1 and alkaline phosphatase function: A unified model of the mechanisms of initiation of skeletal calcification, Journal of Bone and Mineral Research, vol.21, issue.2, pp.286-297, 2011.
DOI : 10.1359/jbmr.020603

K. A. Lomashvili, S. Narisawa, J. L. Millan, and W. C. , Vascular calcification is dependent on plasma levels of pyrophosphate, Kidney International, vol.85, issue.6, pp.1351-1356, 2014.
DOI : 10.1038/ki.2013.521